8-K: Ambac Reports Mixed First Quarter 2025 Results: P&C Growth Offset by Legacy Business Drag

Ambac Financial Group's Q1 2025 results show strong growth in the P&C business, but an overall net loss due to legacy operations and increased expenses.

Summary

• Ambac Financial Group reported its first quarter 2025 results, showing a mixed performance.
• Total revenue from continuing P&C operations increased by 27% to $63 million compared to the first quarter of 2024.
• P&C premium production increased significantly by 70% to $318 million.
• However, the company experienced a net loss attributable to shareholders of $(46.391) million, a decrease of (331)% compared to a net income of $20.070 million in the same period last year.
• The Insurance Distribution segment (Cirrata) saw total revenue grow by 129% to $41 million, but reported a net loss to shareholders of $(2) million.
• The Specialty P&C Insurance segment (Everspan) reported a net income to shareholders of over $1 million, but this was down slightly from the previous year.
• Adjusted EBITDA to shareholders was $(1) million, compared to $0 million in the same prior-year period.
• The company repurchased 264,791 shares at an average price of $11.79 per share during the quarter, with $35.2 million remaining on the repurchase authorization.
• The sale of the Legacy business is pending Wisconsin regulatory approval.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While there's growth in the P&C business, the overall net loss and negative Adjusted EBITDA temper the positive aspects. The pending sale of the Legacy business adds uncertainty.

Positives

• The P&C business showed strong growth, with premium production up 70% and revenue up 27%.
• Cirrata's revenue increased significantly by 129%.
• Everspan's loss ratio improved by -880 bps.
• The company is progressing with the sale of its Legacy business, awaiting final regulatory approval.

Negatives

• The company reported a net loss attributable to shareholders of $(46.391) million.
• Cirrata reported a net loss to shareholders of $(2) million.
• Everspan's net income to shareholders decreased slightly.
• Adjusted EBITDA from continuing operations to Ambac shareholders was negative at $(1) million.
• Total expenses from continuing operations increased by 48% to $78 million.

Risks

• The company's actual results may differ materially from forward-looking statements due to various factors.
• Failure to consummate the proposed sale of AAC could negatively impact the company.
• Inadequacy of reserves established for losses and loss expenses could lead to volatility.
• The company's substantial indebtedness could adversely affect its financial condition and operating flexibility.
• Greater than expected underwriting losses in the specialty property and casualty insurance business could occur.
• The company may face challenges in attracting and retaining qualified personnel.
• The company may face adverse effects of market cycles in the property and casualty insurance industry.

Future Outlook

The company is focused on long-term growth in specialty niches and anticipates the closing of the sale of its Legacy business, pending regulatory approval, to become a leading specialty P&C franchise.

Management Comments

• Claude LeBlanc, President and Chief Executive Officer, stated, 'Our P&C business had a strong start to the year, with premium production up 70% to $318 million and revenue up 27% to $63 million, both compared to the first quarter of 2024, bolstered by our acquisition of Beat.'
• LeBlanc continued, 'We are positioned to continue growing our business by focusing on specialty niches, and I am encouraged by the early indications from the MGAs we launched last year, a few of which are already profitable and all of which are trending towards consistent profitability.'
• LeBlanc continued, 'In addition, as previously announced, we have completed all of our pre-closing conditions related to the the sale of our Legacy business, which remains subject only to Wisconsin regulatory approval.'

Industry Context

The company is focusing on specialty P&C niches, which aligns with a broader industry trend of seeking higher-margin business in specialized areas. The acquisition of Beat Capital is part of this strategy to diversify and grow in these segments.

Comparison to Industry Standards

• It is difficult to compare Ambac's results directly to industry standards without knowing the specific mix of specialty P&C business they are in.
• Companies like RLI Corp. and W. R. Berkley Corporation are known for their strong underwriting performance in specialty lines, often achieving combined ratios below 95%.
• Ambac's Everspan segment has a combined ratio of 102.1%, indicating it is currently not as profitable as some of the top performers in the specialty P&C space.
• However, the improvement in the loss ratio suggests progress in underwriting discipline.

Stakeholder Impact

• Shareholders will be concerned about the net loss, but may be encouraged by the growth in the P&C business and the potential sale of the Legacy business.
• Employees in the P&C and Insurance Distribution segments may see opportunities for growth.
• Customers may benefit from the company's focus on specialty niches.
• Suppliers and creditors will be monitoring the company's financial performance and the progress of the Legacy business sale.

Next Steps

• Awaiting Wisconsin regulatory approval for the sale of the Legacy business.
• Focusing on growing the specialty P&C business and improving profitability.
• Monitoring the performance of recently launched MGAs.
• Participating in an earnings call and webcast on May 13, 2025.

Key Dates

Keywords

Ambac, Financial Results, P&C Insurance, Insurance Distribution, Specialty Insurance, Earnings, EBITDA, Premium Production, Loss Ratio, Share Repurchase